Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,241 total articles

Global Partners LP General Partner Acquires Units to Fulfill Incentive Obligations Amid Mixed Quarterly Results

Global Partners LP General Partner Acquires Units to Fulfill Incentive Obligations Amid Mixed Quarterly Results

Global GP LLC, the general partner entity for Global Partners LP (NASDAQ:GLP), executed two separate acquisitions of 10,000 common units in early June 2026 to meet obligations under the company's Long-Term Incentive Plan. The total expenditure for these transactions reached $493,950, with purchase prices ranging between $48.87 and $50.00 per unit. …

...}, ...} -> Valid JSON. Let's draft carefully. Note:

...}, ...} -> Valid JSON. Let's draft carefully. Note:

...}, ...} -> Valid JSON. Let's draft carefully. Note: I need to make sure the JSON is valid. I will construct it mentally and output it. Wait, the schema says: { title, subtitle, summary, body, tags, news_wire_title, image_prompt, sentiment, impact, ticker, tickers, ticker_sentiment }. I will follow this exactly. I will ensure the body is long eno…

Axon Enterprise Executives and Market Dynamics in Focus

Axon Enterprise Executives and Market Dynamics in Focus

Cameron Brooks, the Chief Revenue Officer at Axon Enterprise, Inc., recently executed a sale of company shares under a pre-established trading plan. This transaction occurs against a backdrop of the company's recent financial performance and broader market valuation metrics, which continue to draw analyst attention and investor scrutiny.

Cushman & Wakefield Executive Divests Shares Amid Strong Q1 Earnings

Cushman & Wakefield Executive Divests Shares Amid Strong Q1 Earnings

Nathaniel Robinson, Executive Vice President and Chief Investment & Strategy Officer at Cushman & Wakefield Ltd. (NYSE: CWK), executed a sale of 24,828 common shares on June 4, 2026. The transaction, valued at $13.25 per share, resulted in a total divestment of $328,971. Post-transaction, Robinson retains a direct holding of 70,876 shares in the co…

United Therapeutics CEO Rothblatt Executes Options and Sells $5.2 Million in Shares Under 10b5-1 Plan

United Therapeutics CEO Rothblatt Executes Options and Sells $5.2 Million in Shares Under 10b5-1 Plan

Martine A. Rothblatt, Chairperson and Chief Executive Officer of United Therapeutics Corp (NASDAQ: UTHR), executed a transaction involving 9,500 shares of the company's common stock on June 5, 2026. The transaction included the exercise of stock options and the subsequent sale of the acquired shares, resulting in a total sale value of approximately…